EUVIMEDOpdag EUVIMED
Crossref

Transforming [ 177 Lu]Lu‐PSMA‐617 treatment planning: Machine learning‐based radiodosiomics and swin UNETR using pretherapy PSMA positron emission tomography/computed tomography (PET/CT)

Elmira Yazdani, Aryan Neizehbaz, Najme Karamzade-Ziarati, Farshad Emami, Habibeh Vosoughi, Mahboobeh Asadi, Atefeh Mahmoudi, Mahdi Sadeghi, Saeed Reza Kheradpisheh, Parham Geramifar

Medical Physics · 2025

DOI: 10.1002/mp.70030 ↗

At a glance

Journal article in Medical Physics, 2025. Written by Elmira Yazdani and 9 co-authors. Institution: Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Major MEDLINE topics: Positron Emission Tomography Computed Tomography, Machine Learning, Lutetium, Radiotherapy Planning, Computer-Assisted. Cited 16 times so far (Crossref); 39 references. Funded by: School of Medicine, Iran University of Medical Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Personalized pretreatment dosimetry planning is crucial for optimizing [ 177 Lu]Lu–prostate‐specific membrane antigen‐617 (Lu‐PSMA) radioligand therapy (RLT) in patients with metastatic castration‐resistant prostate cancer (mCRPC).

Purpose

This study addresses two goals. First, we develop a machine learning (ML)‐based pretreatment planning model to predict post‐therapy absorbed doses (ADs) in metastatic lesions by integrating clinical biomarkers (CBs) with radiomic features (RFs) and dosiomic features (DFs) extracted from [⁶⁸Ga]Ga‐PSMA‐11 (Ga‐PSMA) positron emission tomography/computed tomography (PET/CT), thereby improving predictive accuracy. Second, we develop a transformer‐based deep learning (DL) architecture to predict Monte Carlo (MC)‐derived dose rate maps (DRMs), minimizing reliance on computationally intensive MC simulations.

Methods

For the ML objective, retrospective posttreatment dosimetry data from 20 patients with mCRPC treated with Lu‐PSMA RLT were used as ground truth labels. Patient‐specific MC dosimetry was employed on Ga‐PSMA PET/CT images using the GATE v9.1 toolkit to generate DRMs. After image preprocessing, RFs and DFs were extracted from Ga‐PSMA CT images and DRMs using LIFEx v7.4.0. Multiple feature selection techniques, including recursive feature elimination (RFE), mutual information, Boruta, LASSO, and Elastic Net, were applied and evaluated. The Benjamini‐Hochberg correction ( q < 0.05) was used to control for false discovery rate following each method. Multiple nonlinear regression models were trained using leave‐one‐out cross‐validation (LOOCV), and model interpretability was assessed using SHAP and LIME radar plots. A shifted windows UNET Transformers (Swin UNETR) architecture with self‐supervised learning (SSL) pretraining was employed to predict voxel‐wise PET‐based DRMs for the DL objective. The model was fine‐tuned on MC‐labelled DRM data from 30 patients (including 10 additional cases) using 5‐fold cross‐validation.

Results

Among multiple feature selection strategies, RFE was ultimately selected for final modelling based on its superior predictive performance. The ensemble tree regressor (ETR) using selected CT RFs, PET DFs, and significant CBs achieved an R 2 = 0.82 and RMSE = 0.67 Gy/GBq. For DRM prediction, the SSL‐pretrained Swin UNETR achieved an R 2 of 0.97, NRMSE of 0.003 Gy/GBq, and a Gamma pass rate of 99.08%, closely matching MC‐derived DRMs.

Conclusions

Integrating ML‐based radiodosiomics and transformer‐based DL enables accurate, efficient lesion AD and DRM prediction from pretherapy PET/CT, supporting personalized Lu‐PSMA RLT planning.

Subjects

MeSH terms (MEDLINE)

Positron Emission Tomography Computed TomographyMachine LearningLutetiumRadiotherapy Planning, Computer-AssistedDipeptidesHeterocyclic Compounds, 1-RingHumansRadiometryMaleProstatic Neoplasms, Castration-ResistantMonte Carlo MethodRadiotherapy DosageRetrospective StudiesRadioisotopes

Author keywords

dose predictionmCRPCmachine/deep learningradiomics and dosiomicsradiopharmaceutical therapyself‐supervised learningswin UNETRtreatment planning

Substances

LutetiumDipeptidesHeterocyclic Compounds, 1-RingLutetium-177Radioisotopes

Authors and institutions

  • Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Computer and Data Sciences, Faculty of Mathematical Sciences, Shahid Beheshti University, Tehran, Iran.
  • Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Nuclear Medicine and Molecular Imaging Department, Imam Reza International University, Razavi Hospital, Mashhad, Iran.

Funding

  • School of Medicine, Iran University of Medical Sciences

Cite

APA

Yazdani, E., Neizehbaz, A., Karamzade-Ziarati, N., Emami, F., Vosoughi, H., Asadi, M., Mahmoudi, A., Sadeghi, M., Kheradpisheh, S. R., & Geramifar, P. (2025). Transforming [ 177 Lu]Lu‐PSMA‐617 treatment planning: Machine learning‐based radiodosiomics and swin UNETR using pretherapy PSMA positron emission tomography/computed tomography (PET/CT). Medical Physics. https://doi.org/10.1002/mp.70030

Vancouver

Yazdani E, Neizehbaz A, Karamzade-Ziarati N, Emami F, Vosoughi H, Asadi M, et al. Transforming [ 177 Lu]Lu‐PSMA‐617 treatment planning: Machine learning‐based radiodosiomics and swin UNETR using pretherapy PSMA positron emission tomography/computed tomography (PET/CT). Medical Physics. 2025. doi:10.1002/mp.70030

BibTeX
@article{Yazdani2025,
  author = {Yazdani, Elmira and Neizehbaz, Aryan and Karamzade-Ziarati, Najme and Emami, Farshad and Vosoughi, Habibeh and Asadi, Mahboobeh and Mahmoudi, Atefeh and Sadeghi, Mahdi and Kheradpisheh, Saeed Reza and Geramifar, Parham},
  title = {Transforming [ 177 Lu]Lu‐PSMA‐617 treatment planning: Machine learning‐based radiodosiomics and swin UNETR using pretherapy PSMA positron emission tomography/computed tomography (PET/CT)},
  journal = {Medical Physics},
  year = {2025},
  doi = {10.1002/mp.70030}
}
Start for free →